Synthesis of irreversible HIV-1 protease inhibitors containing sulfonamide and sulfone as amide bond isosteres

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 20, 1997, Pages 2635-2638

  Choy, Nakyen ^a   Choi, Ho Il ^a   Jung, Won Hee ^a   Kim, Chung Ryeol ^a   Yoon, Heungsik ^a   Kim, Sung Chun ^a   Lee, Tae Gyu ^a   Koh, Jong Sung ^a  

^a LG Chemical Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONAL GROUP; PROTEINASE INHIBITOR; SULFONAMIDE; SULFONE;

ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INACTIVATION; HUMAN IMMUNODEFICIENCY VIRUS 1; REACTION ANALYSIS; T LYMPHOCYTE;

EID: 0030668533     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10054-3     Document Type: Article

References (17)

1. Kay, J.; Dunn, B. M. Biochim.Biophys.Acta. 1990, 1048, 1.
2. (a) Kohl, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A.; Scolnick, E. M.; Sigal, I. S. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4686.
3. (b) Peng, C.; Ho, B. K.; Chang, T. W.; Chang, N. T. J. Virol 1989, 63, 2550.
4. Adachi, A.; Ono, N.; Sakai, H.; Ogawa, K.; Shibata, R.; Kiyomasu, T.; Masuike, H.; Ueda, S. Arch. Virol. 1991, 117, 45.
5. Meek, T. D.; Lambert, D. M.; Dreyer, G. B.; Carr, T. J.; Tomaszek, T. A., Jr.; Moore, M. L.; Strickler, J. E.; Debouck, C.; Hyland, L. J.; Matthews, T. J.; Metcalf, B. W.; Petteway, S. R. Nature 1990, 343, 90.
6. (a) Huff, J. R. J. Med. Chem. 1991, 34, 2305.
7. (b) Debouck, C. AIDS Res and Human Retroviruses 1992, 8, 153.
8. (a) Lee, C. S.; Choy, N.; Park, C.; Choi, H.; Son, Y. C.; Kim, S.; Ok, J.; Yoon, H.; Kim, S. C. Bioorg.& Med Chem. Lett. 1996, 6, 589.
9. (b) Park, C.; Koh, J. S.; Son, Y. C.; Choi, H.; Lee, C. S.; Choy, N.; Moon, K. Y.; Jung, W. H.; Kim, S. C.; Yoon, H. Bioorg.& Med. Chem. Lett. 1995, 5, 1843.
10. Swain, M. L.; Miller, M. M.; Green, J.; Rich, D. H.; Schneider, J.; Kent, S. B.; Wlodawer, A. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 8805.
11. Meek, T. D.; Lambert, D. M.; Metcalf, B. W.; Petteway, Jr., S. R.; Dreyer, G. B.; in E. De Clercq " Design of anti-AIDS Drugs", Elsevier, Amsterdam, 1990; pp225-255.
12. (a) Li, Y.-L.; Luthman, K.; Hacksell, U. Tetrahedron Lett. 1992, 33, 4487.
13. (b) Jenmalm, A.; Berts, W.; Li, Y.-L.; Luthman, K.; Csoregh, I.; Hacksell, U. J. Org. Chem. 1994, 59, 1139.
14. 1H NMR data and were homogeneous by TLC and/or HPLC.
15. A part of the results was presented at the Tenth International Conference on AIDS Abstr. 323A in Yokohama, Japan, August 10, 1994.
16. 2)-Phe-Phe-Val-Leu-4-(hydroxymethyl)pyridine ester (BACHEM Chemical Co.) by human cathepsin D was monitored at pH 3.4 using HPLC according to the method of Marossy, K.; Rich, D. H. Anal. Biochem. 1983, 130, 158.
17. 50) of 2 to the host cell lines was higher than 100μM, indicating a high therapeutic index.